FindTrial
Sign In

QM1114-DP

BIOLOGICAL3 trials

Sponsors

Galderma R&D

Conditions

Canthal LinesGlabellar Frown LinesModerate to Severe Glabellar Lines

Phase 3

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
CompletedNCT05148000
Galderma R&DCanthal Lines, Glabellar Frown Lines
Start: 2023-01-23End: 2023-06-23Updated: 2026-05-29
Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines
CompletedNCT05146999
Galderma R&DGlabellar Frown Lines
Start: 2022-05-09End: 2023-09-01Updated: 2024-10-21
A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
CompletedNCT05463965
Galderma R&DModerate to Severe Glabellar Lines
Start: 2022-07-29End: 2023-06-15Updated: 2023-10-12